Global Public Health Partnering Directory 2012-2018: Latest Deal Trends, Players and Financials - ResearchAndMarkets.com

October 3, 2018

DUBLIN--(BUSINESS WIRE)--Oct 3, 2018--The “Global Public Health Partnering 2012-2018: Deal trends, players and financials” report has been added to ResearchAndMarkets.com’s offering.

The Global Public Health Partnering 2012-2018 report provides comprehensive access to available deals and contract documents for over 200 public health deals.

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor’s product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Public Health disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Public Health deals.

The report presents financial deal terms values for Public Health deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Public Health dealmaking 2.1. Introduction 2.2. Public Health partnering over the years 2.3. Public Health partnering by deal type 2.4. Public Health partnering by industry sector 2.5. Public Health partnering by stage of development 2.6. Public Health partnering by technology type 2.7. Public Health partnering by therapeutic indication

Chapter 3 - Financial deal terms for Public Health partnering 3.1. Introduction 3.2. Disclosed financials terms for Public Health partnering 3.3. Public Health partnering headline values 3.4. Public Health deal upfront payments 3.5. Public Health deal milestone payments 3.6. Public Health royalty rates

Chapter 4 - Leading Public Health deals and dealmakers 4.1. Introduction 4.2. Most active in Public Health partnering 4.3. List of most active dealmakers in Public Health 4.4. Top Public Health deals by value

Chapter 5 - Public Health contract document directory 5.1. Introduction 5.2. Public Health partnering deals where contract document available

Chapter 6 - Public Health dealmaking by therapeutic target 6.1. Introduction 6.2. Deals by Public Health therapeutic target

Appendices Appendix 1 - Directory of Public Health deals by company A-Z 2012 to 2018 Appendix 2 - Directory of Public Health deals by deal type 2012 to 2018 Appendix 3 - Directory of Public Health deals by stage of development 2012 to 2018 Appendix 4 - Directory of Public Health deals by technology type 2012 to 2018

For more information about this report visit https://www.researchandmarkets.com/research/ndpggs/global_public?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181003005435/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Pharmaceuticals



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 10/03/2018 07:34 AM/DISC: 10/03/2018 07:34 AM


Update hourly